Core Viewpoint - Ark Health (06086) has shown significant growth in its mid-year performance, with a notable increase in revenue and net profit, alongside a strategic partnership with Novo Nordisk to enhance its healthcare services [1] Financial Performance - The company reported a revenue of 1.494 billion HKD for the first half of the year, representing a year-on-year growth of 12.9% [1] - Net profit turned positive, reaching 12.5 million HKD, while adjusted net profit hit a record high of 17.6 million HKD, up 16.8% year-on-year [1] - Online retail pharmacy service revenue was 864 million HKD, showing a substantial increase of 28.2% year-on-year [1] - Comprehensive medical service revenue amounted to 357 million HKD, reflecting a year-on-year growth of 11.4% [1] Strategic Developments - Ark Health has signed a strategic cooperation memorandum with Novo Nordisk, a leading global biopharmaceutical company [1] - The partnership aims to leverage Ark Health's AI and internet medical capabilities to create a comprehensive health management service covering medication guidance, reminders, effect tracking, and health education [1] - The initiative focuses on transforming diabetes and obesity management from a "disease-centered" approach to a "health-centered" model, providing patients with improved and convenient one-stop services [1]
港股异动 | 方舟健客(06086)午后涨超8% 上半年业绩表现亮眼 公司近期与诺和诺德达成战略合作